Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$gmab Graphic](https://lunarcrush.com/gi/w:26/t:$gmab.png) $gmab

Genmab is acquiring Merus for $X billion, leading to a surge in community engagement and positive sentiment around the project.

### About $gmab
A cryptocurrency project.  

### Engagements: XXXXX [#](/topic/$gmab/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX +183%  
**1-Year High**: XXXXXXX on 2025-10-06  
**1-Year Low**: XX on 2025-10-18  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$gmab/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XXX +54%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: XX on 2025-10-18  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XX [#](/topic/$gmab/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $gmab in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +105%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: XX on 2025-10-18  

The most influential creators that mention $gmab in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@SamFazeli8](/creator/twitter/SamFazeli8)           | X    | XXXXX     | X     | XXX         |
| [@investseekers](/creator/twitter/investseekers)     | X    | XXXXX     | XX    | XXX         |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)       | X    | XXX       | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XX          |
| [@MichelleF_Davis](/creator/twitter/MichelleF_Davis) | X    | XXXXX     | X     | XX          |
| [@bio_clouseau](/creator/twitter/bio_clouseau)       | X    | XXXXXX    | X     | XX          |
| [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | X    | XXX       | X     | XX          |
| [@PhilipHemme](/creator/twitter/PhilipHemme)         | X    | XXXXX     | X     | XX          |
| [@Quality_stocksA](/creator/twitter/Quality_stocksA) | X    | XXXXXX    | X     | XX          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/$gmab/100)
  
  
### Sentiment: XX% [#](/topic/$gmab/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$gmab/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$gmab/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +9%  
**1-Year High**: XXX% on 2025-05-10  
**1-Year Low**: XX% on 2025-09-14  

**Most Supportive Themes**
- **Community Engagement:** (45%) Positive sentiment around project updates and community involvement.
- **Technological Advancements:** (30%) Excitement regarding new features and technological progress.
  
**Most Critical Themes**
- **Market Volatility:** (15%)  Concerns about price fluctuations and market uncertainty.
- **Competition:** (10%)  Discussion of competing projects and their potential impact.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXXXX   | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXXXX   | XX% | XX       | X% |
  


**Top assets mentioned**
In the posts about $gmab in the last XX hours

[Merus N.V. Common Shares (MRUS)](/topic/$mrus)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Johnson & Johnson (JNJ)](/topic/$jnj)
[Novo-Nordisk (NVO)](/topic/$nvo)
[BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Merck & Co., Inc. (MRK)](/topic/$mrk)

**Top topics mentioned**
In the posts about $gmab in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$gmabco](/topic/$gmabco), [$mrus](/topic/$mrus), [stocks technology](/topic/stocks-technology), [stocks financial services](/topic/stocks-financial-services), [johnson johnson](/topic/johnson-johnson), [stocks](/topic/stocks), [$jnj](/topic/$jnj), [acquisition](/topic/acquisition), [$nvo](/topic/$nvo), [$bmrn](/topic/$bmrn), [$azn](/topic/$azn), [$8b](/topic/$8b), [investment](/topic/investment), [stocks banks](/topic/stocks-banks), [$pfe](/topic/$pfe), [$abbv](/topic/$abbv), [$ggndf](/topic/$ggndf), [$novcde](/topic/$novcde), [denmark](/topic/denmark), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [targets](/topic/targets), [$argx](/topic/$argx), [$bntx](/topic/$bntx), [$mrk](/topic/$mrk), [$psnl](/topic/$psnl), [danish krone](/topic/danish-krone), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [combo](/topic/combo), [$bbio](/topic/$bbio), [$xbi](/topic/$xbi), [costa rican colon](/topic/costa-rican-colon), [$asnd](/topic/$asnd), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$bmy](/topic/$bmy), [stocks industrials](/topic/stocks-industrials), [$pypl](/topic/$pypl), [$elan](/topic/$elan), [os](/topic/os), [$novob](/topic/$novob), [$dsv](/topic/$dsv), [davis](/topic/davis), [fl](/topic/fl), [vertex protocol](/topic/vertex-protocol), [$glo](/topic/$glo), [$uuuu](/topic/$uuuu), [$oco](/topic/$oco), [coins defi](/topic/coins-defi), [breakthrough](/topic/breakthrough), [stocks communication services](/topic/stocks-communication-services), [$367b](/topic/$367b), [$hrmy](/topic/$hrmy), [$smci](/topic/$smci), [$banc](/topic/$banc), [hims hers](/topic/hims-hers), [$wise](/topic/$wise), [$97share](/topic/$97share), [medtronic](/topic/medtronic), [$hca](/topic/$hca), [taiwan semiconductor](/topic/taiwan-semiconductor), [$pfewhite](/topic/$pfewhite), [new york stock exchange](/topic/new-york-stock-exchange), [phd](/topic/phd), [stocks basic materials](/topic/stocks-basic-materials), [$wpm](/topic/$wpm), [$dnli](/topic/$dnli), [$hmy](/topic/$hmy), [bloomberg](/topic/bloomberg), [$vgk](/topic/$vgk), [$iev](/topic/$iev), [$ezu](/topic/$ezu), [$sobi](/topic/$sobi), [$cinf](/topic/$cinf), [$cytk](/topic/$cytk), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [$52b](/topic/$52b), [$54share](/topic/$54share), [$6share](/topic/$6share), [goldman sachs](/topic/goldman-sachs), [$gww](/topic/$gww), [$dsnky](/topic/$dsnky), [$43b](/topic/$43b), [ares capital corp](/topic/ares-capital-corp), [procter gamble](/topic/procter-gamble), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$zlab](/topic/$zlab), [$pfes](/topic/$pfes), [china](/topic/china), [$acgl](/topic/$acgl), [$qcom](/topic/$qcom), [$calm](/topic/$calm), [$209b](/topic/$209b), [microsoft](/topic/microsoft), [$spgi](/topic/$spgi), [united states dollar](/topic/united-states-dollar), [investments](/topic/investments), [make a](/topic/make-a), [$75b](/topic/$75b)

### Top Social Posts [#](/topic/$gmab/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$AZN $PFE $LLY $GILD $NVO $GSK $JNJ $GMAB $MRUS $ZLDPF $RHHBY $MTSR $ABBV $MRK $NVS $SNN $ZBH Listen to Washington J&J Orpho Spin Eyecare Merus Deal: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud"  
[X Link](https://x.com/SamFazeli8/status/1979126760215065009) [@SamFazeli8](/creator/x/SamFazeli8) 2025-10-17T10:06Z 2881 followers, XXX engagements


"Denmark - Equity Highlights Most Active: - $NOVO-B / Novo Nordisk A/S - Favourable (-8 Rangebound) - $DSV / DSV A/S - Favourable (+11 Trending Higher) - $GMAB / Genmab A/S - Unfavourable (+20 Overbought) Best Darwin Scores: - $DANSKE / Danske Bank A/S - Favourable (+38 Rangebound) - $MAERSK-A / A.P. Mller - Mrsk A/S - Favourable (+34 Rangebound) - $MAERSK-B / A.P. Mller - Mrsk A/S - Favourable (+32 Rangebound) Worst Darwin Scores: - $NOVO-B / Novo Nordisk A/S - Favourable (-8 Rangebound) - $PNDORA / Pandora A/S - Favourable (-3 Rangebound) - $ORSTED / Oersted A/S - Favourable (-1 Trending"  
[X Link](https://x.com/Darwin_Knows/status/1979023791255929030) [@Darwin_Knows](/creator/x/Darwin_Knows) 2025-10-17T03:16Z XXX followers, XXX engagements


"MajesTEC-3 is the first Phase X study to show that the combination of TECVAYLI and DARZALEX FASPRO offers better PFS and OS than current standards of care $GMAB $JNJ"  
[X Link](https://x.com/DrPaulyDeSantis/status/1978868070560207090) [@DrPaulyDeSantis](/creator/x/DrPaulyDeSantis) 2025-10-16T16:58Z 7668 followers, XXX engagements


"The Danish C25 index closed up XXX% on Thursday. $GMAB rose XXX% after partner $JNJ reported improved survival rates in a combo cancer study with Tecvayli and Darzalex Faspro. $NVO gained XXX% as BNP Paribas Exane raised its price target to DKK XXX (from 345) while Handelsbanken cut its target to DKK XXX (from 525). #StocksToWatch #investing #Denmark"  
[X Link](https://x.com/investseekers/status/1978861620810883374) [@investseekers](/creator/x/investseekers) 2025-10-16T16:32Z 4110 followers, 1490 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$gmab Graphic $gmab

Genmab is acquiring Merus for $X billion, leading to a surge in community engagement and positive sentiment around the project.

About $gmab

A cryptocurrency project.

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +183%
1-Year High: XXXXXXX on 2025-10-06
1-Year Low: XX on 2025-10-18

Social Network X
Engagements XXXXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX +54%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-10-18

Social Network X
Mentions XXX

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $gmab in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Month: XXX +105%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-10-18

The most influential creators that mention $gmab in the last XX hours

Creator Rank Followers Posts Engagements
@SamFazeli8 X XXXXX X XXX
@investseekers X XXXXX XX XXX
@Darwin_Knows X XXX X XXX
@BiopharmIQ X XXXXXX X XX
@MichelleF_Davis X XXXXX X XX
@bio_clouseau X XXXXXX X XX
@EgidiusLambrech X XXX X XX
@PhilipHemme X XXXXX X XX
@Quality_stocksA X XXXXXX X XX
@MarcJacksonLA XX XXXXX X XX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +9%
1-Year High: XXX% on 2025-05-10
1-Year Low: XX% on 2025-09-14

Most Supportive Themes

  • Community Engagement: (45%) Positive sentiment around project updates and community involvement.
  • Technological Advancements: (30%) Excitement regarding new features and technological progress.

Most Critical Themes

  • Market Volatility: (15%) Concerns about price fluctuations and market uncertainty.
  • Competition: (10%) Discussion of competing projects and their potential impact.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXXXX XX% XX X%
Total XXX XX% XXXXX XX% XX X%

Top assets mentioned In the posts about $gmab in the last XX hours

Merus N.V. Common Shares (MRUS) Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Novo-Nordisk (NVO) BioMarin Pharmaceutical, Inc. (BMRN) AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) AbbVie Inc (ABBV) Regeneron Pharmaceuticals Inc (REGN) Merck & Co., Inc. (MRK)

Top topics mentioned In the posts about $gmab in the last XX hours

stocks healthcare, $gmabco, $mrus, stocks technology, stocks financial services, johnson johnson, stocks, $jnj, acquisition, $nvo, $bmrn, $azn, $8b, investment, stocks banks, $pfe, $abbv, $ggndf, $novcde, denmark, regeneron pharmaceuticals inc, targets, $argx, $bntx, $mrk, $psnl, danish krone, stocks consumer cyclical, eli lilly, $lly, combo, $bbio, $xbi, costa rican colon, $asnd, stocks bitcoin treasuries, $bmy, stocks industrials, $pypl, $elan, os, $novob, $dsv, davis, fl, vertex protocol, $glo, $uuuu, $oco, coins defi, breakthrough, stocks communication services, $367b, $hrmy, $smci, $banc, hims hers, $wise, $97share, medtronic, $hca, taiwan semiconductor, $pfewhite, new york stock exchange, phd, stocks basic materials, $wpm, $dnli, $hmy, bloomberg, $vgk, $iev, $ezu, $sobi, $cinf, $cytk, akro akero therapeutics inc, $52b, $54share, $6share, goldman sachs, $gww, $dsnky, $43b, ares capital corp, procter gamble, stocks consumer defensive, $zlab, $pfes, china, $acgl, $qcom, $calm, $209b, microsoft, $spgi, united states dollar, investments, make a, $75b

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$AZN $PFE $LLY $GILD $NVO $GSK $JNJ $GMAB $MRUS $ZLDPF $RHHBY $MTSR $ABBV $MRK $NVS $SNN $ZBH Listen to Washington J&J Orpho Spin Eyecare Merus Deal: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud"
X Link @SamFazeli8 2025-10-17T10:06Z 2881 followers, XXX engagements

"Denmark - Equity Highlights Most Active: - $NOVO-B / Novo Nordisk A/S - Favourable (-8 Rangebound) - $DSV / DSV A/S - Favourable (+11 Trending Higher) - $GMAB / Genmab A/S - Unfavourable (+20 Overbought) Best Darwin Scores: - $DANSKE / Danske Bank A/S - Favourable (+38 Rangebound) - $MAERSK-A / A.P. Mller - Mrsk A/S - Favourable (+34 Rangebound) - $MAERSK-B / A.P. Mller - Mrsk A/S - Favourable (+32 Rangebound) Worst Darwin Scores: - $NOVO-B / Novo Nordisk A/S - Favourable (-8 Rangebound) - $PNDORA / Pandora A/S - Favourable (-3 Rangebound) - $ORSTED / Oersted A/S - Favourable (-1 Trending"
X Link @Darwin_Knows 2025-10-17T03:16Z XXX followers, XXX engagements

"MajesTEC-3 is the first Phase X study to show that the combination of TECVAYLI and DARZALEX FASPRO offers better PFS and OS than current standards of care $GMAB $JNJ"
X Link @DrPaulyDeSantis 2025-10-16T16:58Z 7668 followers, XXX engagements

"The Danish C25 index closed up XXX% on Thursday. $GMAB rose XXX% after partner $JNJ reported improved survival rates in a combo cancer study with Tecvayli and Darzalex Faspro. $NVO gained XXX% as BNP Paribas Exane raised its price target to DKK XXX (from 345) while Handelsbanken cut its target to DKK XXX (from 525). #StocksToWatch #investing #Denmark"
X Link @investseekers 2025-10-16T16:32Z 4110 followers, 1490 engagements

$gmab
/topic/$gmab